Current Issue

Top Keywords

Subscribe today to our complimentary e-Newsletters and stay abreast of the latest biotech news and trends.

THIS KEYWORD IS SPONSORED BY:

Feature Articles: Stem Cell Initiatives at Sanford Consortium for Regenerative Medicine
Medulloblastoma, the Most Malignant Brain Cancer in Children, Is One Current Focus
Feature Articles: Regenerative Medicine Looks to the Future
Feature Articles: Regenerative Medicine Back on Fast Track
After decades of frustratingly slow progress, regenerative medicine is buoyed by optimism.
Feature Articles: Stem Cell Applications Hasten into the Clinic
Corporate Profiles: Industrial Quantities of IPSCs Now Possible
CDI Offers Stem Cell Products for Studies on Heart, Liver, CNS, and Endothelial Tissue

Republican Candidates Vouch for Agency Spending Cuts and hESC Restrictions
February 16, 2012
While details differ, Romney, Gingrich, Santorum, and Paul all want to slice FDA and NIH’s budget.
California Stem Cell Agency’s Road to Success for Next Five Years Will Have to Run Through the Clinic
January 24, 2012
As CIRM considers direction and required financing going forward, it will have to show progress to win support.
Academic Institutions Won Most of CIRM’s $1.3B in Awards over Past Five Years
January 23, 2012
Focus of California’s stem cell agency has been on setting up a foundation for leadership.
Where Does Geron’s Exit from Embryonic Stem Cells Leave the Field?
November 28, 2011
Given that the firm with the most money has just quit, questions about how to succeed are rampant.
Implementation of European Court Decision to Ban hESC Patents Depends on National Patent Offices
November 16, 2011
Stakeholders are concerned that member states could interpret the court’s ruling differently.

NEW INITIATIVE FOR MAPPING ALL CELL TYPES DERIVED FROM HUMAN EMBRYONIC STEM CELLS
- Interview with Michael West, Ph.D., Chief Executive Officer, BioTime, Inc.
RESEARCHERS CREATE BEATING HEART IN THE LABORATORY
- Interview with Doris Taylor, Ph.D., Director of the University of Minnesota Center for Cardiovascular Repair and Medtronic Bakken Professor of Medicine and Physiology

	Life Technologies Stem Cell Culture Medium StemPro® MSC SFM liquid stem cell culture medium is intended for human ex vivo tissue and cell culture. It is designed to efficiently grow large amounts of human mesenchymal stem cells (MSCs) while maintaining their undifferentiated state. As an
	GigaCyte Human Hippocampal Stem Cells These human hippocampal stem cells have been launched for use in neuroscience and cytotoxicity testing. These cells have been extensively characterized for neural stem cell and mature neural markers. This human organ-derived product differentiates i
	EMD Millipore Lentivirus Reprogramming Kit The new Human Stemcca™ lentivirus reprogramming kit generates induced pluripotent stem (iPS) cells from human adult cells. The humanized version of the Stemcca lentivirus expresses human Oct4, Klf4, Sox2, and c-Myc factors from a single polyci
	Life Technologies iPSC Generation CytoTune™-iPS reprogramming kit is used for developing induced pluripotent stem cells from human somatic cells. The CytoTune kit is based on zero-footprint technology that employs an RNA virus developed by DNAvec. The benign vectors are effect
	Cellular Dynamics Human Endothelial Cells Human iCell® endothelial cells are now available for use in vascular-targeted drug discovery, tissue regeneration, and other life science research. iCell endothelial cells are derived from human induced pluripotent stem (iPS) cells, actively pro

Bioprocessing and Stem Cells Europe
2012 June 27 - June 28 London, , UNITED KINGDOM
Stem Cell & Regenerative Medicine
2012 October 24 - October 26 San Francisco, CA, UNITED STATES
8th World Stem Cell Summit
2012 December 3 - December 5 West Palm Beach, FL, UNITED STATES

GEN MAGAZINE
	Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization. Subscribe

e-NEWSLETTERS
Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
GEN Daily News Highlights - provides succinct and timely biotech news on the entire biotech field. GEN News Highlights of the Week - showcases the week's top biotech news. GEN Table of Contents (TOC) Alert - This alert provides a sneak peak at the latest issue of GEN. GEN Tech Focus - is published monthly to provide the latest advances in biotech's hottest topics. GEN Biotech Events - a weekly newsletter featuring webinars, meetings, and conferences. GEN New Products Watch - a monthly summary of products and services by tool providers. New product information and special offers from select biotech suppliers.
	All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format


	Sign Up